SEVENTEEN YEARS EXPERIENCE OF EBRT PLUS HDR BRACHYTHERAPY BOOST IN HIGH-RISK LOCALIZED PROSTATE CANCER PATIENTS: A COMPETING RISKS ANALYSIS

被引：0
|
作者：
Carignan, Damien [1 ]
Despres, Philippe [1 ]
Magnan, Sindy [2 ]
Froment, Marie-Anne [2 ]
Foster, William [2 ]
Aubin, Sylviane [2 ]
Lavallee, Marie-Claude [2 ]
Lacroix, Frederic [2 ]
Cantin, Audrey [2 ]
Poulin, Eric [2 ]
Martin, Andre-Guy [2 ]
Vigneault, Eric [2 ]
机构：
[1] Univ Laval, Quebec City, PQ, Canada
[2] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 150卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：S9 / 510
页数：2
相关论文
共 50 条
  • [41] HDR Brachytherapy in the Management of High-Risk Prostate Cancer (Vol 2012, 980841, 2012)
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    [J]. ADVANCES IN UROLOGY, 2016, 2016
  • [42] Brachytherapy boost and cancer-specific mortality in favorable high-risk and other high-risk prostate cancer.
    Muralidhar, Vinayak
    Xiang, MIchael H.
    Orio, Peter F.
    Martin, Neil E.
    Beard, Clair
    Feng, Felix Yi-Chung
    Hoffman, Karen E.
    Nguyen, Paul L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [43] Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer
    Muralidhar, Vinayak
    Xiang, Michael
    Orio, Peter F., III
    Martin, Neil E.
    Beard, Clair J.
    Feng, Felix Y.
    Hoffman, Karen E.
    Nguyen, Paul L.
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2016, 8 (01) : 1 - 6
  • [44] THE IMPACT OF ANDROGEN-DEPRIVATION THERAPY ON CERAMIDES, A POTENTIAL BIOMARKER OF OUTCOMES OF PROSTATE CANCER FOR PATIENTS TREATED WITH EBRT AND HDR BRACHYTHERAPY BOOST
    Carignan, Damien
    Bourgeois, Marine
    Foster, William
    Martin, Andre-Guy
    Paris, Francois
    Vigneault, Eric
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S77 - S78
  • [45] HDR brachytherapy boost improves metastatic free survival in high and very-high risk prostate cancer
    Visus, I.
    Barco, A.
    Obeso, J.
    Barrado, M.
    Sola, A.
    Villafranca, E.
    Fuentemilla, N.
    Pellejero, S.
    Navarrete, P.
    Martinez, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S536 - S537
  • [46] Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.
    Gonzalez-Motta, Alejandro
    Roach, Mack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data
    Novikov, S.
    Kanaev, S.
    Novikov, R.
    Ilin, N.
    Gotovchikova, M.
    Girshovitch, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S202 - S203
  • [48] EFFICACY, TOXICITY AND DOSIMETRIC ASPECTS OF HDR BRACHYTHERAPY IN PROSTATE CANCER PATIENTS: 4 YEARS EXPERIENCE
    Filipowski, T.
    Dorota, K.
    Anna, S. T.
    Wiktor, N.
    Barbara, P. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S282 - S282
  • [49] Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer
    Berg, Sebastian
    Cole, Alexander P.
    Krimphove, Marieke J.
    Nabi, Junaid
    Marchese, Maya
    Lipsitz, Stuart R.
    Noldus, Joachim
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    [J]. EUROPEAN UROLOGY, 2019, 75 (04) : 552 - 555
  • [50] CLINICAL OUTCOME OF INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY plus EXTERNAL BEAM RADIOTHERAPY (EBRT) FOR EARLY STAGE PROSTATE CANCER
    Aluwini, S.
    van Rooij, P.
    Jansen, P.
    Praag, J.
    Bangma, C.
    Kirkels, W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S24 - +
12345